Concepedia

Katherine A. Freitas

KA

7

Publications

795

Citations

7

H-Index

2021

Active since

Affiliations

Stanford University(Current)

Parker Institute for Cancer Immunotherapy

Gladstone Institutes

Chan Zuckerberg Initiative (United States)

University of California, Berkeley

Katherine A. Freitas is an author at Stanford University specializing in crispr, gene expression, and medicine.

ORCID

Top concepts

Publications per year

2021–2024

7

Publications

7

Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence

Julia A. Belk, Winnie Yao, Nghi Ly et al. · Cancer Cell · 2022 · 316 citations · Full text

, , +9

Enhanced T cell effector activity by targeting the Mediator kinase module

Katherine A. Freitas, Julia A. Belk, Elena Sotillo et al. · Science · 2022 · 125 citations · Full text

Inosine induces stemness features in CAR-T cells and enhances potency

Dorota D. Klysz, Carley Fowler, Meena Malipatlolla et al. · Cancer Cell · 2024 · 119 citations · Full text

Engineered CD47 protects T cells for enhanced antitumour immunity

Sean A. Yamada‐Hunter, Johanna Theruvath, Brianna J. McIntosh et al. · Nature · 2024 · 96 citations · Full text

NOT-Gated CD93 CAR T Cells Effectively Target AML with Minimized Endothelial Cross-Reactivity

Rebecca M. Richards, Feifei Zhao, Katherine A. Freitas et al. · Blood Cancer Discovery · 2021 · 86 citations · Full text

Rows per page

1–5 of 7